GlassScriptPhysician profile
Christopher J Burnett
NPI 1376736785
$6,151.49
in general payments reported to CMS, 2019-2025
19 companies · $2,351 in 2025
The $2,351 reported for 2025 was more than what 85% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $242 · 2021: $267 · 2022: $659 · 2023: $481 · 2024: $1,548 · 2025: $2,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,379.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,831.99 | 2019-2025 | Eterna, Proclaim, Octrode |
| Medtronic, INC. | $889.51 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Boston Scientific Corporation | $809.03 | 2019-2025 | General - Pain Management, Intracept, General - Therapies |
| Nevro Corp. | $804.67 | 2019-2024 | Senza |
| Si-Bone, INC. | $546.81 | 2019-2025 | |
| Globus Medical, INC. | $289.22 | 2025 | Omnia, Senza |
| Medtronic USA, INC. | $208.46 | 2019-2020 | |
| Vertiflex, INC. | $149.04 | 2019 | |
| Relievant Medsystems, INC. | $137.59 | 2022-2023 | Intracept |
| Spr Therapeutics, INC | $114.51 | 2025 | Sprint Pns System |
| E.R. Squibb & Sons, L.L.C. | $96.66 | 2025 | Cobenfy |
| Stryker Corporation | $55.27 | 2025 | Augment Injectable |
| Valinor Pharma, LLC | $39.37 | 2025 | Movantik |
| Avanos Medical | $37.74 | 2021-2023 | Coolief* Cooled Radiofrequency |
| Stimwave Technologies Incorporated | $36.21 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mindray Ds USA, INC. | $30.80 | 2024 | Te X, Te7 Max |
| Saluda Medical Americas, INC. | $28.74 | 2025 | Evoke |
| Averitas Pharma INC. | $26.02 | 2023 | Qutenza |
| Spinal Simplicity, LLC | $19.85 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Burnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.